Evidence map›Paper›PMID 40791051›Full record

Trial reportActas espanolas de psiquiatria2025

Two is Better Than One: Potentiating Cognitive Remediation With Aerobic Exercise to Improve Cognition in Schizophrenia With a Randomized Controlled Trial.

Giulia Agostoni, Federica Repaci, Margherita Bechi, Irene Calzavara Pinton, Mariachiara Buonocore, Marco Spangaro, Jacopo Sapienza, Francesca Martini, Elisabetta D'Antoni, Beatrice Giglio and 6 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Actas espanolas de psiquiatria, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Giulia AgostoniVita-Salute San Raffaele University, 20132 Milan, Italy; Department of Clinical Neurosciences, IRCCS San Raffaele Scientific Institute, 20127 Milan, Italy.
Federica RepaciDepartment of Clinical Neurosciences, IRCCS San Raffaele Scientific Institute, 20127 Milan, Italy.
Margherita BechiDepartment of Clinical Neurosciences, IRCCS San Raffaele Scientific Institute, 20127 Milan, Italy.
Irene Calzavara PintonDepartment of Molecular and Translational Medicine, University of Brescia, 25122 Brescia, Italy.
Mariachiara BuonocoreDepartment of Clinical Neurosciences, IRCCS San Raffaele Scientific Institute, 20127 Milan, Italy.
Marco SpangaroDepartment of Clinical Neurosciences, IRCCS San Raffaele Scientific Institute, 20127 Milan, Italy.
Jacopo SapienzaDepartment of Clinical Neurosciences, IRCCS San Raffaele Scientific Institute, 20127 Milan, Italy; University School for Advanced Studies (IUSS), 27100 Pavia, Italy.
Francesca MartiniDepartment of Clinical Neurosciences, IRCCS San Raffaele Scientific Institute, 20127 Milan, Italy.
Elisabetta D'AntoniVita-Salute San Raffaele University, 20132 Milan, Italy.
Beatrice GiglioVita-Salute San Raffaele University, 20132 Milan, Italy.
Federica CocchiDepartment of Clinical Neurosciences, IRCCS San Raffaele Scientific Institute, 20127 Milan, Italy.
Carmelo GuglielminoDepartment of Clinical Neurosciences, IRCCS San Raffaele Scientific Institute, 20127 Milan, Italy.
Antonio VitaDepartment of Clinical and Experimental Sciences, University of Brescia, 25122 Brescia, Italy; Department of Mental Health and Addiction Services, ASST Valcamonica, 25040 Esine, Italy.
Roberto CavallaroVita-Salute San Raffaele University, 20132 Milan, Italy; Department of Clinical Neurosciences, IRCCS San Raffaele Scientific Institute, 20127 Milan, Italy.
Giacomo DesteDepartment of Clinical and Experimental Sciences, University of Brescia, 25122 Brescia, Italy; Department of Mental Health and Addiction Services, ASST Valcamonica, 25040 Esine, Italy.
Marta BosiaVita-Salute San Raffaele University, 20132 Milan, Italy; Department of Clinical Neurosciences, IRCCS San Raffaele Scientific Institute, 20127 Milan, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCognitive impairment is a core feature of schizophrenia, for which pharmacological interventions have limited efficacy. Cognitive remediation (CR) is the gold standard for addressing cognitive deficits, yet its effect remains in the low-to-medium range, thus enhanced treatment approaches are needed. Emerging evidence supports the cognitive benefits of Aerobic Exercise (AE), suggesting that a combined intervention of AE and CR could lead to greater cognitive enhancements. This study aims at evaluating, with a randomized controlled trial, cognitive improvements following a combined intervention of CR+AE, compared to either CR or AE alone in patients diagnosed with schizophrenia.

methodsSixty patients with schizophrenia were randomized into three groups (AE, CR, or CR+AE), and assessed for cognition, with the MATRICS Consensus Cognitive Battery at baseline, post-intervention, and at a 3-month follow-up.

resultsCR+AE group showed significantly greater improvements in several domains including attention (p = 0.02), verbal learning (p = 0.03), and working memory (p = 0.04) compared to CR group, as well as processing speed (p = 0.002), verbal learning (p = 0.03), and working memory (p = 0.05) compared to AE group. At 3-months follow-up, evaluating CR+AE vs CR, further significant improvements were observed for social cognition (p = 0.01) in the CR+AE group, as well as for processing speed (p = 0.03) in the CR group.

conclusionsWhile preliminary, these findings suggest that a combined intervention of CR+AE allows greater improvements across core cognitive domains. In a wider perspective, this study also underscores the potential value of implementing aerobic exercise in rehabilitative approaches aimed at addressing cognitive dysfunction in schizophrenia.

Indexed as

Cognitive DysfunctionCognitive RemediationExerciseExercise TherapySchizophreniaAdultCognitionCombined Modality TherapyFemaleHumansMaleMiddle AgedSchizophrenic PsychologyTreatment Outcome

Identifiers

PMID40791051
PMCPMC12353237

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.